Intracameral cefuroxime in the prevention of postoperative endophthalmitis

Intracameral cefuroxime in the prevention of postoperative endophthalmitis Graefes Arch Clin Exp Ophthalmol (2017) 255:1681–1682 DOI 10.1007/s00417-017-3686-x LETTER TO THE EDITOR Intracameral cefuroxime in the prevention of postoperative endophthalmitis 1 1,2 Louis W. Lim & Colin S. Tan Received: 29 March 2017 /Accepted: 24 April 2017 /Published online: 13 May 2017 Springer-Verlag Berlin Heidelberg 2017 Dear Editor, In the current study, patients seem to have had worse visual In a recent publication, Ng et al. [1] evaluated the efficacy and outcomes than those in other studies, despite coagulase- safety of intracameral cefuroxime following cataract surgery, negative staphylococcus being the dominant organism. Only and reported that the Buse of intracameral cefuroxime could one patient had visual acuity (VA) of better than 0.1, with three eyes requiring evisceration. In contrast, previous studies [3, 6, significantly reduce the rate of postoperative endophthalmitis.^ Many studies conducted among different populations have 7] have shown that up to 28.6% of patients were able to main- reported significant reductions in the rate of postoperative en- tain a final VA of 20/20 to 20/40. We are curious whether the dophthalmitis when intracameral antibiotics were introduced authors identified any particular reason for the visual out- [2–5]. The optimal choice of antibiotic, however, remains the comes. They http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Graefe's Archive for Clinical and Experimental Ophthalmology Springer Journals

Intracameral cefuroxime in the prevention of postoperative endophthalmitis

Loading next page...
 
/lp/springer_journal/intracameral-cefuroxime-in-the-prevention-of-postoperative-CIsBAfERB0
Publisher
Springer Berlin Heidelberg
Copyright
Copyright © 2017 by Springer-Verlag Berlin Heidelberg
Subject
Medicine & Public Health; Ophthalmology
ISSN
0721-832X
eISSN
1435-702X
D.O.I.
10.1007/s00417-017-3686-x
Publisher site
See Article on Publisher Site

Abstract

Graefes Arch Clin Exp Ophthalmol (2017) 255:1681–1682 DOI 10.1007/s00417-017-3686-x LETTER TO THE EDITOR Intracameral cefuroxime in the prevention of postoperative endophthalmitis 1 1,2 Louis W. Lim & Colin S. Tan Received: 29 March 2017 /Accepted: 24 April 2017 /Published online: 13 May 2017 Springer-Verlag Berlin Heidelberg 2017 Dear Editor, In the current study, patients seem to have had worse visual In a recent publication, Ng et al. [1] evaluated the efficacy and outcomes than those in other studies, despite coagulase- safety of intracameral cefuroxime following cataract surgery, negative staphylococcus being the dominant organism. Only and reported that the Buse of intracameral cefuroxime could one patient had visual acuity (VA) of better than 0.1, with three eyes requiring evisceration. In contrast, previous studies [3, 6, significantly reduce the rate of postoperative endophthalmitis.^ Many studies conducted among different populations have 7] have shown that up to 28.6% of patients were able to main- reported significant reductions in the rate of postoperative en- tain a final VA of 20/20 to 20/40. We are curious whether the dophthalmitis when intracameral antibiotics were introduced authors identified any particular reason for the visual out- [2–5]. The optimal choice of antibiotic, however, remains the comes. They

Journal

Graefe's Archive for Clinical and Experimental OphthalmologySpringer Journals

Published: May 13, 2017

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off